Stanford University
Showing 7,551-7,600 of 34,423 Results
-
Matthew Drause
Affiliate, IT Services
BioMatthew Drause is originally from Rochester Hills, MI. Prior to attending the Yale Physician Associate Program, he worked as a high school history teacher. He started his career at Harborview Medical Center in Seattle, WA where he worked in inpatient Neurosurgery before transitioning to the APP Lead for Trauma Surgery. He started at Stanford Healthcare in 2024 as the Lead APP for inpatient Plastic Surgery, Urology and Pulmonary Hypertension. Outside of his passion for medicine he enjoys outdoor activities including mountaineering, rock climbing, and backpacking. He is passionate about healthcare equity, patient experience, and improving patient access.
-
Persis S. Drell
Provost, Emerita, James and Anna Marie Spilker Professor, Professor of Materials Science and Engineering and of Physics
BioPersis Drell is the James and Anna Marie Spilker Professor in the School of Engineering, a professor of materials science and engineering, and a professor of physics. From Feb 1, 2017 to Sept. 30, 2023, Drell was the provost of Stanford University.
Prior to her appointment as provost in February 2017, she was dean of the Stanford School of Engineering from 2014 to 2017 and director of U.S. Department of Energy SLAC National Acceleratory Laboratory from 2007 to 2012.
She earned her bachelor’s degree in mathematics and physics from Wellesley College and her PhD in atomic physics from UC Berkeley. Before joining the faculty at Stanford in 2002, she was a faculty member in the physics department at Cornell University for 14 years. -
Leora Dresselhaus-Marais
Assistant Professor of Materials Science and Engineering, of Photon Science and, by courtesy, of Mechanical Engineering
Current Research and Scholarly InterestsMy group develops new methods to update old processes in metals manufacturing
-
Juliana 'Julie' Dresvina
Overseas Studies - Oxford, Bing Overseas Studies
BioI am a medievalist and cultural historian; my work combines history, literary criticism, art history, and psychology. One of my current research projects explores how people use self-narratives — creative, devotional, or non-fiction — as a form of therapeutic practice. I am also interested in how human-shaped spaces of spiritual significance, along with religious material objects, function therapeutically: from devotional manuscripts and misericord carvings to rock sanctuaries, holy wells, and thermal springs.
I have published monographs with Oxford University Press and Brill, and I teach interdisciplinary courses on cultural history, literature, psychology, and art, as well as do study skills mentoring. -
Taran Driver
Casual - Non-Exempt, LCLS - Linac Coherent Light Source
BioI gained my PhD from the Blackett Laboratory Laser Consortium at Imperial College London, where my primary research project was the development of a new type of mass spectrometry for the structural analysis of protein, DNA and RNA molecules. This technology is known as two-dimensional partial-covariance mass spectrometry (2D PC MS). Here at Stanford I work at the Linac Coherent Light Source (LCLS), using the attosecond X-ray pulses produced by the newly developed XLEAP mode to study ultrafast electronic processes in molecules. We are developing and using new spectroscopic methods in the attosecond regime to observe the motion of electrons in complex molecular systems on their natural timescale. This helps us to understand how the coherent quantum dynamics of these electronic systems affect subsequent chemical motion.
-
Ron Dror
Cheriton Family Professor and Professor, by courtesy, of Structural Biology and of Molecular & Cellular Physiology
Current Research and Scholarly InterestsMy lab’s research focuses on computational biology, with an emphasis on 3D molecular structure. We combine two approaches: (1) Bottom-up: given the basic physics governing atomic interactions, use simulations to predict molecular behavior; (2) Top-down: given experimental data, use machine learning to predict molecular structures and properties. We collaborate closely with experimentalists and apply our methods to the discovery of safer, more effective drugs.
-
David Drover
Professor of Anesthesiology, Perioperative and Pain Medicine (MSD), Emeritus
Current Research and Scholarly InterestsField of clinical pharmacology. This involves analysis of what the body does to a drug (pharmacokinetics) and how exactly a specific drug affects the body (pharmacodynamics). His research starts at the level of new drug development with detailed analysis of the pharmacokinetics and pharmacodynamics of a medication.
-
Shaul Druckmann
Associate Professor of Neurobiology, of Psychiatry and Behavioral Sciences and, by courtesy, of Electrical Engineering
Current Research and Scholarly InterestsOur research goal is to understand how dynamics in neuronal circuits relate and constrain the representation of information and computations upon it. We adopt three synergistic strategies: First, we analyze neural circuit population recordings to better understand the relation between neural dynamics and behavior, Second, we theoretically explore the types of dynamics that could be associated with particular network computations. Third, we analyze the structural properties of neural circuits.
-
Maurice L. Druzin
Professor of Obstetrics and Gynecology (Maternal Fetal Medicine and Obstetrics), Emeritus
Current Research and Scholarly InterestsAntepartum and intrapartum fetal monitoring Prenatal diagnosis Medical complications of pregnancy, particularly: SLE, hypertension, diabetes, malignancy A.
-
Jinhong Du
Postdoctoral Scholar, Chemistry
BioFrom chemist to targeted therapy designer, and now biophysicist—I keep pushing across disciplines, hoping every new boundary crossed brings a few unexpected discoveries.
-
Justin Du Bois
Henry Dreyfus Professor of Chemistry and Professor, by courtesy, of Chemical and Systems Biology
BioThe Du Bois lab is heavily invested in exploring voltage-gated ion channel function and physiology and the underlying role of specific channels in human pathologies, particularly nociception, epilepsy, and neurodevelopmental disorders. With expertise in chemical synthesis, we have access to a collection of exceptional natural products—tetrodotoxin, saxitoxin, gonyautoxin, batrachotoxin, veratridine, antillatoxin, to name a few—that act as selective modulators of sodium ion channels (NaVs). In addition, we have developed novel molecules as inhibitors and agonists of specific voltage-gated chloride (ClCs) and calcium (CaVs) channel isoforms. As a lab, we are uniquely positioned to advance high-precision chemical tools to interrogate underlying biochemical mechanisms of electrogenesis. Our work in this arena is guided by a number of questions related to the basic functioning of voltage-gated channels in neuronal cells and glia that include: 1) what is the rate at which channels are being made and degraded and is the rate of channel turnover context dependent (i.e., is protein turnover affected by increased neuronal activity, nerve cell damage, etc.); 2) to what extent is channel expression and cellular distribution affected by external factors (pH, inflammatory modulators, injury); 3) how do post-translational protein modifications influence channel function and how are such modifications altered in response to external factors; 4) how do neighboring glia influence channel expression and ion gating. Answers to these types of questions will provide a deeper understanding of the molecular mechanisms by which neuronal cells and tissue respond to external stimuli, stress, and injury. We benefit from the strong interest of others in our work and multiple collaborators at Stanford and at other institutions.
Ion channel function and physiology. We wish to understand the role of individual subtypes of voltage-gated sodium, chloride, and calcium channels in neuronal signaling and how structural changes (i.e., point mutations, post-translational modifications, partner proteins) alter channel function. Our interests include the design, development, and application of chemogenetic technologies for targeting individual channel subtypes and allosteric modulators of select channel isoforms. Our work aims to inform efforts in translational research, as voltage-gated ion channel dysregulation and malfunction underlie a wide range of human diseases and disorders.
Natural products synthesis. We are interested in developing efficient and flexible synthetic routes to natural products that serve as ‘lead’ compounds for advancing high precision pharmacological tools. Most of the targets we are interested in obtaining are not available in sufficient quantities from natural sources, thus necessitating de novo preparation. To streamline the assembly process of these complex molecules, we are challenged to develop, in parallel, new tactics and chemical methods that facilitate C–C, C–N, and C–O bond formation.
Toxin ‘sponge’ proteins. A longstanding collaboration with the Minor lab at UCSF has focused on understanding how certain organisms that ingest dietary toxins such as saxitoxin, tetrodotoxin, and batrachotoxin survive their poisonous effects. This work has resulted in the elucidation of the structures of novel paralytic shellfish-binding proteins (so-called saxiphilins) and the toxin ‘binding code’. Studies are ongoing to integrate saxiphilins into a diagnostic device for measuring toxin concentrations in shellfish and to advance an engineered toxin-binding protein as a countermeasure for paralytic shellfish poisoning.
